Global Asthma Drugs Market Landscape: Trends and Market Share to 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Asthma Drugs Industry?
The size of the asthma medications market has been experiencing consistent growth over the past few years. The market, which was worth $23.96 billion in 2024, is anticipated to increase to $24.93 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.0%. Factors contributing to this growth during the historical period include environmental elements, a rise in respiratory ailments, changes in lifestyle, and advancements in healthcare infrastructure.
The market for asthma medication is anticipated to experience significant expansion in the coming years. The market is projected to increase to “$31.38 billion in 2029, with a compound annual growth rate (CAGR) of 5.9%. This projected growth during the forecast period can be linked to factors such as escalating levels of air pollution, an aging population, heightened healthcare awareness, the trend towards personalized medicine, and innovations in biopharmaceuticals. The forecast period is projected to see trends like therapies using small molecules, at-home asthma care, treatments guided by biomarkers, advancements in therapies for severe asthma, and partnerships for asthma research.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11924&type=smp
#Which Factors Are Currently Driving The Growth Of The Asthma Drugs Market?
The asthma drug market is predicted to expand due to the high incidence of asthmatic conditions. Asthma is a chronic condition characterized by inflammation and swelling of the airways, which subsequently leads to a narrowing of the airways that transport air from the nose and mouth to the lungs. The rising number of asthma cases has led to a heightened focus on the discovery of new asthma medications for the treatment of such conditions. For example, Asthma + Lung UK, a charity based in England that aids people with respiratory issues, reported that in 2021, there were 1,146 asthma-related deaths in the country. This number troublingly increased to 1,236 in 2022, indicating a growing trend in deaths linked to the disease throughout the year.
How Is The Global Asthma Drugs Market Structured In Terms Of Segments?
The asthma drugs market covered in this report is segmented –
1) By Type Of Asthma: Allergic, Non-Allergic
2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma
3) By Therapy: Preventive, Curative
4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs
5) By End-User: Asthma Patients, COPD Patients
Subsegments:
1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies
2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids
How Are Key Trends Driving Expansion In The Asthma Drugs Industry?
Leading firms in the asthma drugs market are prioritizing innovative advancements such as fixed-dose combination (FDC) drugs in order to improve the effectiveness of treatments and patient compliance. An FDC drug includes two or more active substances that are combined in one dosage form, like a capsule, tablet, or inhaler. Glenmark Pharmaceuticals, a pharmaceutical company based in India, as an example, launched a FDC drug named Indamet in June 2022 for patients whose asthma is not controlled. This innovative medication merges Indacaterol, a long-lasting beta-agonist, and Mometasone Furoate, an inhaled corticosteroid. It comes in a variety of strengths including Indacaterol 150 mcg with Mometasone at 80 mcg, 160 mcg, and 320 mcg, and is meant for once-daily usage, focusing on adolescents and adults aged twelve and above.
Who Are The Main Participants Shaping The Asthma Drugs Market Landscape?
Major companies operating in the asthma drugs market include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd, Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc., Atopix Therapeutics Limited
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report
Which Region Currently Holds The Largest Share In The Asthma Drugs Market?
North America was the largest region in the asthma drugs market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=11924&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
